Journal
CLINICAL IMMUNOLOGY
Volume 216, Issue -, Pages -Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2020.108459
Keywords
COVID-19; SARS-CoV-2; Coronavirus; Intravenous immunoglobulin; Hyperimmune globulin
Categories
Funding
- Eleanor and Miles Shore 50th Anniversary Fellowship Award
- Samara Turkel Foundation
- Perkin Fund
- [5T32AI00751234]
- [1K08AI116979-01]
- [1R01AI13963301]
Ask authors/readers for more resources
The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
